InvestorsHub Logo
Followers 46
Posts 1362
Boards Moderated 0
Alias Born 08/09/2015

Re: None

Monday, 12/28/2020 8:39:42 AM

Monday, December 28, 2020 8:39:42 AM

Post# of 458192
Perhaps dilution is not an ugly word for Anavex at this stage. In reading today's announcement, it is expanding its clinical trials with drugs based on sound science and backed by studies. Dilution is undoubtedly a factor in analyzing early biotech stocks, but I believe astute investors weigh the totality of circumstances. I am pleased to see Anavex well funded at this stage in its development. I am happy to see that Anavex is in a position to build on its successes.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News